Giuseppina Opinto

643 total citations
16 papers, 354 citations indexed

About

Giuseppina Opinto is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Giuseppina Opinto has authored 16 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Giuseppina Opinto's work include Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (3 papers) and Advanced Breast Cancer Therapies (2 papers). Giuseppina Opinto is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (3 papers) and Advanced Breast Cancer Therapies (2 papers). Giuseppina Opinto collaborates with scholars based in Italy. Giuseppina Opinto's co-authors include Attilio Guarini, Sabino Ciavarella, Eugenio Maiorano, Giacomo Loseto, Carla Minoia, Miriam Dellino, Erica Silvestris, Claudia Cormio, Annalisa Savonarola and Oronzo Brunetti and has published in prestigious journals such as Oncotarget, BMC Cancer and Cancers.

In The Last Decade

Giuseppina Opinto

16 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppina Opinto Italy 10 189 104 55 48 47 16 354
Nadeem Bilani United States 10 161 0.9× 82 0.8× 35 0.6× 18 0.4× 31 0.7× 38 364
Sasha Lupichuk Canada 10 157 0.8× 86 0.8× 25 0.5× 17 0.4× 21 0.4× 29 328
Feng Yao China 12 178 0.9× 204 2.0× 52 0.9× 49 1.0× 48 1.0× 22 468
Kandace L. Amend United States 7 230 1.2× 99 1.0× 56 1.0× 15 0.3× 13 0.3× 12 410
Darren Walker United States 6 85 0.4× 136 1.3× 15 0.3× 23 0.5× 24 0.5× 11 341
Michaela Onstad United States 10 304 1.6× 158 1.5× 55 1.0× 16 0.3× 62 1.3× 24 736
Nava Siegelmann‐Danieli Israel 15 277 1.5× 151 1.5× 84 1.5× 25 0.5× 12 0.3× 57 644
Alessandro De Luca Italy 13 200 1.1× 74 0.7× 91 1.7× 10 0.2× 26 0.6× 46 521
Yisheng Tao China 13 158 0.8× 275 2.6× 35 0.6× 28 0.6× 35 0.7× 32 506
Bogdan Michalski Poland 10 134 0.7× 82 0.8× 38 0.7× 7 0.1× 27 0.6× 20 339

Countries citing papers authored by Giuseppina Opinto

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Opinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Opinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Opinto more than expected).

Fields of papers citing papers by Giuseppina Opinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Opinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Opinto. The network helps show where Giuseppina Opinto may publish in the future.

Co-authorship network of co-authors of Giuseppina Opinto

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Opinto. A scholar is included among the top collaborators of Giuseppina Opinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Opinto. Giuseppina Opinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zaccaria, Gian Maria, Maria Carmela Vegliante, Giacomo Volpe, et al.. (2023). A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants. HemaSphere. 7(4). e862–e862. 5 indexed citations
2.
Silvestris, Erica, Carla Minoia, Attilio Guarini, et al.. (2022). Ovarian Stem Cells (OSCs) from the Cryopreserved Ovarian Cortex: A Potential for Neo-Oogenesis in Women with Cancer-Treatment Related Infertility: A Case Report and a Review of Literature. Current Issues in Molecular Biology. 44(5). 2309–2320. 5 indexed citations
3.
Ingravallo, Giuseppe, Roberto Tamma, Giuseppina Opinto, et al.. (2022). The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. Diagnostics. 12(3). 573–573. 7 indexed citations
4.
Musto, Pellegrino, Luca Mastracci, Giuseppina Opinto, et al.. (2022). Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma. Current Oncology. 29(9). 6115–6124. 1 indexed citations
5.
Esposito, Flavia, Maria Carmela Vegliante, Giuseppina Opinto, et al.. (2021). A New Ensemble Method for Detecting Anomalies in Gene Expression Matrices. Mathematics. 9(8). 882–882. 11 indexed citations
6.
Opinto, Giuseppina, Claudio Agostinelli, Sabino Ciavarella, et al.. (2021). Hodgkin Lymphoma: A Special Microenvironment. Journal of Clinical Medicine. 10(20). 4665–4665. 17 indexed citations
7.
Opinto, Giuseppina, Maria Carmela Vegliante, Antonio Negri, et al.. (2020). The Tumor Microenvironment of DLBCL in the Computational Era. Frontiers in Oncology. 10. 351–351. 26 indexed citations
8.
Romito, Francesca, Miriam Dellino, Giacomo Loseto, et al.. (2020). Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic. Frontiers in Oncology. 10. 1270–1270. 91 indexed citations
9.
Mangia, Anita, Concetta Saponaro, Giuseppina Opinto, et al.. (2019). Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?. Cancers. 11(9). 1393–1393. 14 indexed citations
10.
Mangia, Anita, Emanuela Scarpi, Laura Schirosi, et al.. (2017). NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients. Oncotarget. 8(39). 65730–65742. 13 indexed citations
11.
Opinto, Giuseppina, Nicola Silvestris, Giusi Graziano, et al.. (2017). Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype. Oncotarget. 8(50). 87782–87794. 2 indexed citations
12.
Schirosi, Laura, Annalisa Mazzotta, Giuseppina Opinto, et al.. (2016). β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients. Oncotarget. 7(42). 67841–67850. 14 indexed citations
13.
Marinaccio, Christian, Giuseppe Ingravallo, Francesco Gaudio, et al.. (2015). T cells, mast cells and microvascular density in diffuse large B cell lymphoma. Clinical and Experimental Medicine. 16(3). 301–306. 15 indexed citations
14.
Simone, Valeria De, Sabino Ciavarella, Oronzo Brunetti, et al.. (2015). Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells. BMC Cancer. 15(1). 692–692. 99 indexed citations
15.
Marinaccio, Christian, Giuseppe Giudice, Eleonora Nacchiero, et al.. (2015). Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density. Clinical and Experimental Medicine. 16(3). 383–389. 6 indexed citations
16.
Opinto, Giuseppina, Annalisa Natalicchio, & Piero Marchetti. (2013). Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity. Archives of Physiology and Biochemistry. 119(4). 170–178. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026